https://old.international-biopharma.com/vertex-faces-first-notable-setback-as-it-pushes-beyond-cystic-fibrosis-2/ 2020-10-26T09:32:55+00:00 https://old.international-biopharma.com/roche-aiming-to-make-better-gene-therapies-turns-to-an-emerging-startup/ 2020-10-19T08:45:29+00:00 https://old.international-biopharma.com/lilly-wagers-135m-on-a-startups-plan-to-stop-neurodegeneration/ 2020-10-19T08:43:55+00:00 https://old.international-biopharma.com/vertex-faces-first-notable-setback-as-it-pushes-beyond-cystic-fibrosis/ 2020-10-19T08:42:27+00:00 https://old.international-biopharma.com/pfizer-wont-seek-fda-clearance-of-coronavirus-vaccine-until-mid-november-ceo-says/ 2020-10-19T08:40:10+00:00 https://old.international-biopharma.com/early-signs-of-survival-benefit-raise-optimism-around-a-small-biotechs-als-drug/ 2020-10-19T08:38:29+00:00 https://old.international-biopharma.com/nestle%e2%80%8b-makes-newly-acquired-aimmune-a-stand-alone-unit-appoints-new-ceo/ 2020-10-19T08:36:12+00:00 https://old.international-biopharma.com/precision-for-medicine/ 2020-10-06T08:59:04+00:00 https://old.international-biopharma.com/wp-content/uploads/2020/10/PFM-World-Map-Image-2.png https://old.international-biopharma.com/delivering-viable-high-quality-leukapheresis-product-via-advanced-cold-storage-solutions/ 2020-10-05T13:59:00+00:00 https://old.international-biopharma.com/exosome-therapeutics-academic-curiosity-or-commercial-reality/ 2020-10-05T13:55:42+00:00 https://old.international-biopharma.com/non-clinical-safety-evaluation-of-vaccine-strategic-considerations-to-accelerate-clinical-development/ 2020-10-05T13:52:02+00:00 https://old.international-biopharma.com/accelerating-regenerative-medicine-approaches-to-type-1-diabetes-through-direct-cell-reprogramming/ 2020-10-05T13:49:06+00:00 https://old.international-biopharma.com/analysing-carbohydrates-with-ion-chromatography-to-develop-better-vaccines/ 2020-10-05T13:45:49+00:00 https://old.international-biopharma.com/unlocking-the-therapeutic-potential-of-antimicrobial-natural-products-with-synthetic-biology/ 2020-10-05T13:42:30+00:00 https://old.international-biopharma.com/faster-drug-discovery-with-picodroplet-technologies/ 2020-10-05T13:38:25+00:00 https://old.international-biopharma.com/ensuring-reproducibility-in-biomedical-research-the-role-of-data-metadata-and-emerging-best-practices/ 2020-10-05T13:26:29+00:00 https://old.international-biopharma.com/re-programming-cho-by-gene-editing-the-new-frontier-in-bioprocessing/ 2020-10-05T13:18:38+00:00 https://old.international-biopharma.com/addressing-the-challenges-of-selective-and-sensitive-bioanalytical-assay-development/ 2020-10-05T13:15:15+00:00 https://old.international-biopharma.com/the-power-of-recombinant-human-albumin-new-advances-in-cell-therapy-optimisation-cryopreservation-and-formulation-for-novel-therapies/ 2020-10-05T13:06:56+00:00 https://old.international-biopharma.com/patenting-antibodies-at-the-european-patent-office-2/ 2020-10-05T13:02:08+00:00 https://old.international-biopharma.com/building-a-patient-centric-cgt-supply-chain/ 2020-10-05T12:59:01+00:00 https://old.international-biopharma.com/scenic-biotech-forms-drug-development-alliance-with-genentech/ 2020-09-23T12:43:32+00:00 https://old.international-biopharma.com/blueprints-bet-on-itself-pays-off-with-rare-disease-drug-data/ 2020-09-23T12:42:22+00:00 https://old.international-biopharma.com/merck-matches-roche-in-search-for-next-cancer-immunotherapy/ 2020-09-23T12:40:41+00:00 https://old.international-biopharma.com/with-eli-lilly-data-another-drug-emerges-to-stop-breast-cancers-from-returning-2/ 2020-09-23T12:37:30+00:00 https://old.international-biopharma.com/regeneron-forges-ahead-in-lung-cancer-but-will-need-more-to-unseat-merck/ 2020-09-23T12:34:36+00:00 https://old.international-biopharma.com/amgens-kras-drug-can-shrink-tumors-for-months-but-new-data-leave-room-for-improvement/ 2020-09-23T12:33:03+00:00 https://old.international-biopharma.com/lilly-offers-first-evidence-that-its-antibody-drug-may-help-treat-covid-19/ 2020-09-21T09:03:22+00:00 https://old.international-biopharma.com/arrowhead-shares-soar-on-liver-disease-data-from-four-patients/ 2020-09-21T08:56:27+00:00 https://old.international-biopharma.com/moderna-and-pfizer-having-shown-speed-with-coronavirus-vaccines-see-opportunity-in-seasonal-flu/ 2020-09-21T08:49:50+00:00 https://old.international-biopharma.com/seattle-genetics-stays-step-ahead-of-rivals-with-bladder-cancer-data/ 2020-09-21T08:47:36+00:00 https://old.international-biopharma.com/in-unexpected-finding-roche-claims-arthritis-drug-may-have-role-in-treating-covid-19/ 2020-09-21T08:46:15+00:00 https://old.international-biopharma.com/with-eli-lilly-data-another-drug-emerges-to-stop-breast-cancers-from-returning/ 2020-09-21T08:44:06+00:00 https://old.international-biopharma.com/2025-will-see-cell-and-gene-therapy-capacity-shortages-in-the-usa-and-10-mab-approvals-in-china/ 2020-09-21T08:35:50+00:00 https://old.international-biopharma.com/former-fda-commissioner-dr-scott-gottlieb-to-address-industry-on-sustainable-innovation-at-cphi-festival-of-pharma/ 2020-09-14T08:48:14+00:00 https://old.international-biopharma.com/fda-wants-more-details-on-sarepta-gene-therapy-potentially-delaying-final-test-2/ 2020-09-14T08:46:04+00:00 https://old.international-biopharma.com/merck-takes-aim-at-pfizer-with-pneumonia-vaccine-data/ 2020-09-14T08:44:22+00:00 https://old.international-biopharma.com/intra-cellular-roars-back-on-success-in-bipolar-depression/ 2020-09-14T08:42:54+00:00 https://old.international-biopharma.com/catalent-to-invest-130m-in-gene-therapy-plant-near-baltimore-airport/ 2020-09-14T08:41:26+00:00 https://old.international-biopharma.com/fda-wants-more-details-on-sarepta-gene-therapy-potentially-delaying-final-test/ 2020-09-14T08:36:25+00:00 https://old.international-biopharma.com/gilead-to-buy-cancer-drugmaker-immunomedics-for-21b/ 2020-09-14T08:25:07+00:00 https://old.international-biopharma.com/sanofi-ends-research-of-arthritis-drug-as-coronavirus-treatment/ 2020-09-07T08:33:56+00:00 https://old.international-biopharma.com/gilead-deal-reignites-optimism-in-a-cancer-biotech/ 2020-09-07T08:32:23+00:00 https://old.international-biopharma.com/nih-panel-says-data-doesnt-support-plasma-use-for-covid-19/ 2020-09-07T08:30:52+00:00 https://old.international-biopharma.com/intercept-facing-long-road-ahead-for-nash-drug-lays-off-quarter-of-workforce/ 2020-09-07T08:29:19+00:00 https://old.international-biopharma.com/sanofi-gsk-racing-to-catch-up-begin-first-human-study-of-coronavirus-vaccine/ 2020-09-07T08:27:09+00:00 https://old.international-biopharma.com/amarin-loses-appeal-of-court-ruling-on-heart-drug-patents/ 2020-09-07T08:24:56+00:00 https://old.international-biopharma.com/cansino-canada-abandon-plans-for-a-coronavirus-vaccine-trial/ 2020-09-01T09:35:28+00:00 https://old.international-biopharma.com/new-data-from-jj-arrowhead-mark-latest-step-in-rnais-hepatitis-b-race/ 2020-09-01T09:28:16+00:00 https://old.international-biopharma.com/modernas-vaccine-may-have-an-edge-when-immunization-programs-roll-out/ 2020-09-01T09:19:07+00:00 https://old.international-biopharma.com/with-latest-data-a-gene-therapy-for-a-deadly-brain-disease-inches-closer-to-market/ 2020-09-01T09:14:21+00:00 https://old.international-biopharma.com/ionis-changing-its-strategy-reels-its-spinoff-back-in/ 2020-09-01T09:00:02+00:00 https://old.international-biopharma.com/nestle-buys-the-rest-of-aimmune-aiming-to-boost-a-struggling-peanut-allergy-treatment/ 2020-09-01T08:57:42+00:00 https://old.international-biopharma.com/lilly-doubles-down-on-innovent-cancer-drug-in-immunotherapy-push/ 2020-08-24T12:35:08+00:00 https://old.international-biopharma.com/regeneron-enlists-roche-to-boost-production-of-covid-19-antibody-drug/ 2020-08-24T12:33:25+00:00 https://old.international-biopharma.com/mylan-launches-copy-of-biogens-top-drug-despite-ongoing-court-battle/ 2020-08-24T12:13:14+00:00 https://old.international-biopharma.com/brief-curevac-in-talks-to-supply-eu-with-coronavirus-vaccine/ 2020-08-24T12:11:47+00:00 https://old.international-biopharma.com/in-major-surprise-fda-rejects-high-profile-therapies-from-biomarin-gilead/ 2020-08-24T12:09:55+00:00 https://old.international-biopharma.com/brief-momenta-shift-to-new-drugs-pays-off-with-6-5b-buyout-by-jj/ 2020-08-24T12:08:24+00:00 https://old.international-biopharma.com/bristol-myers-pledges-to-spend-300m-on-addressing-racial-health-disparities/ 2020-08-17T09:39:00+00:00 https://old.international-biopharma.com/thermo-fisher-deal-for-qiagen-falls-apart-after-companies-fail-to-secure-investor-backing/ 2020-08-17T09:34:07+00:00 https://old.international-biopharma.com/argentina-mexico-line-up-to-produce-astrazeneca-oxford-coronavirus-vaccine/ 2020-08-17T09:31:24+00:00 https://old.international-biopharma.com/europe-trailing-us-uk-reaches-first-coronavirus-vaccine-deal/ 2020-08-17T09:29:47+00:00 https://old.international-biopharma.com/fda-gives-speedy-approval-to-another-duchenne-drug/ 2020-08-17T09:27:06+00:00 https://old.international-biopharma.com/curevac-grabs-213m-in-us-ipo-adding-to-years-record-pace/ 2020-08-17T09:25:08+00:00 https://old.international-biopharma.com/pfizer-to-help-gilead-produce-covid-19-drug-remdesivir/ 2020-08-10T09:14:33+00:00 https://old.international-biopharma.com/moderna-sets-high-price-in-early-coronavirus-vaccine-supply-deals/ 2020-08-10T09:10:25+00:00 https://old.international-biopharma.com/biogen-makes-a-billion-dollar-bet-on-parkinsons-drugs/ 2020-08-10T09:06:10+00:00 https://old.international-biopharma.com/fda-agrees-to-review-biogens-alzheimers-drug/ 2020-08-10T09:00:24+00:00 https://old.international-biopharma.com/trump-tries-to-revamp-drug-supply-chain-with-latest-order/ 2020-08-10T08:46:05+00:00 https://old.international-biopharma.com/first-oral-drug-for-spinal-muscular-atrophy-approved-by-fda/ 2020-08-10T08:41:53+00:00 https://old.international-biopharma.com/can-sanofis-top-drug-carry-it-through-a-pandemic/ 2020-08-03T12:19:40+00:00 https://old.international-biopharma.com/astrazeneca-signals-it-wont-wait-for-us-data-to-seek-clearance-of-coronavirus-vaccine/ 2020-08-03T12:18:14+00:00 https://old.international-biopharma.com/jj-beginning-first-human-trial-aims-for-a-1-shot-coronavirus-vaccine/ 2020-08-03T12:16:53+00:00 https://old.international-biopharma.com/5-fda-approval-decisions-to-watch-in-the-3rd-quarter/ 2020-08-03T10:46:33+00:00 https://old.international-biopharma.com/moderna-secures-almost-500m-more-as-it-starts-first-large-scale-us-study-of-coronavirus-vaccine/ 2020-08-03T10:44:50+00:00 https://old.international-biopharma.com/building-a-better-healthcare-cluster/ 2020-07-28T13:54:18+00:00 https://old.international-biopharma.com/unique-challenges-and-opportunities-in-orphan-diseases/ 2020-07-28T13:49:45+00:00 https://old.international-biopharma.com/geroscience-and-the-exposome/ 2020-07-28T13:45:22+00:00 https://old.international-biopharma.com/betting-on-the-bug-part-iii-leveraging-the-microbiome-to-generate-new-models/ 2020-07-28T13:41:21+00:00 https://old.international-biopharma.com/mass-spectrometry-supports-development-of-new-oligonucleotide-therapeutics/ 2020-07-28T13:22:49+00:00 https://old.international-biopharma.com/congenital-hyperinsulinism-treatment-gaps-and-a-potential-solution/ 2020-07-28T13:18:25+00:00 https://old.international-biopharma.com/increasing-patient-access-to-advanced-therapies-the-uk-perspective/ 2020-07-28T13:13:43+00:00 https://old.international-biopharma.com/the-new-drugs-and-clinical-trial-rules-of-india-a-regulatory-highlights/ 2020-07-28T13:09:43+00:00 https://old.international-biopharma.com/go-to-market-challenges-of-car-t-therapies/ 2020-07-28T13:06:07+00:00 https://old.international-biopharma.com/developing-plasmid-dna-production-platforms-to-support-novel-gene-therapies/ 2020-07-28T13:01:29+00:00 https://old.international-biopharma.com/driving-the-commercialisation-of-regenerative-medicine/ 2020-07-28T12:56:27+00:00 https://old.international-biopharma.com/how-the-biopharmaceutical-industry-is-responding-to-patient-demand-for-injection-alternatives/ 2020-07-28T12:45:17+00:00 https://old.international-biopharma.com/sgs-joins-with-biophytis-to-launch-its-international-clinical-trial-of-covid-19-related-respiratory-failure-treatment/ 2020-07-27T10:31:40+00:00 https://old.international-biopharma.com/gilead-adds-to-string-of-cancer-drug-deals-with-tizona-stake/ 2020-07-27T10:27:54+00:00 https://old.international-biopharma.com/oxford-coronavirus-vaccine-spurs-immune-responses-appears-safe-on-first-look/ 2020-07-27T10:25:49+00:00 https://old.international-biopharma.com/moderna-pacing-a-global-vaccine-race-loses-a-key-patent-fight/ 2020-07-27T10:23:53+00:00 https://old.international-biopharma.com/eqrx-gearing-up-for-a-price-war-with-big-pharma-buys-two-cancer-drugs/ 2020-07-27T10:21:40+00:00 https://old.international-biopharma.com/gileads-second-act-in-cell-therapy-gets-its-first-approval/ 2020-07-27T10:07:53+00:00 https://old.international-biopharma.com/abbvies-drip-feed-of-patents-shields-top-cancer-drug-from-competition-group-says/ 2020-07-20T09:13:45+00:00 https://old.international-biopharma.com/side-effects-dont-stop-fda-panel-from-backing-gsk-blood-cancer-drug/ 2020-07-20T09:11:36+00:00 https://old.international-biopharma.com/novartis-says-it-wont-profit-from-sale-of-generic-covid-19-drugs-to-lower-income-countries/ 2020-07-20T09:10:13+00:00 https://old.international-biopharma.com/preventive-studies-for-eisai-biogen-alzheimers-drug-could-add-years-to-amyloid-debate/ 2020-07-20T09:08:30+00:00 https://old.international-biopharma.com/jj-on-the-cusp-of-starting-coronavirus-vaccine-trials-sets-high-bar-for-success/ 2020-07-20T09:05:13+00:00 https://old.international-biopharma.com/sanofi-on-the-lookout-for-acquisitions-may-have-spotted-a-target/ 2020-07-20T09:02:11+00:00 https://old.international-biopharma.com/johnson-johnson-announces-european-commission-approval-for-janssens-preventive-ebola-vaccine/ 2020-07-13T09:17:19+00:00 https://old.international-biopharma.com/big-pharma-battling-covid-19-looks-to-buy-time-on-another-health-crisis-superbugs/ 2020-07-13T09:03:53+00:00 https://old.international-biopharma.com/fda-documents-reveal-doubts-about-gsk-blood-cancer-drug/ 2020-07-13T08:51:44+00:00 https://old.international-biopharma.com/in-the-hunt-for-als-treatments-researchers-find-promise-in-silencing-genes/ 2020-07-13T08:48:01+00:00 https://old.international-biopharma.com/biogen-submitted-its-alzheimers-drug-for-approval-now-what/ 2020-07-13T08:43:28+00:00 https://old.international-biopharma.com/in-the-uk-a-coronavirus-study-shows-how-to-get-fast-powerful-data-during-a-pandemic/ 2020-07-13T08:41:06+00:00 https://old.international-biopharma.com/ultragenyx-wins-early-approval-for-rare-disease-drug/ 2020-07-06T09:28:17+00:00 https://old.international-biopharma.com/gilead-pricing-suggests-it-will-make-a-business-out-of-covid-19-drug/ 2020-07-06T09:26:55+00:00 https://old.international-biopharma.com/fda-insists-it-will-not-cut-corners-in-coronavirus-vaccine-approvals/ 2020-07-06T09:25:39+00:00 https://old.international-biopharma.com/amgen-prevails-in-high-stakes-drug-case-against-novartis/ 2020-07-06T09:24:04+00:00 https://old.international-biopharma.com/coronavirus-vaccine-from-pfizer-biontech-shows-early-potential/ 2020-07-06T09:22:48+00:00 https://old.international-biopharma.com/novartis-to-pay-678m-to-settle-claims-over-sham-doctor-events/ 2020-07-06T09:21:10+00:00 https://old.international-biopharma.com/cphi-festival-of-pharma-to-support-and-lead-global-pharma-industry-forward-with-new-digital-experience-in-2020/ 2020-07-01T13:29:36+00:00 https://old.international-biopharma.com/with-new-proposal-trump-administration-tries-to-encourage-value-based-drug-deals/ 2020-06-22T09:00:27+00:00 https://old.international-biopharma.com/uniqure-gets-out-the-gate-first-in-race-for-huntingtons-gene-therapy/ 2020-06-22T08:52:47+00:00 https://old.international-biopharma.com/in-big-year-for-microbiome-drugs-a-small-biotech-sets-the-bar/ 2020-06-22T08:50:29+00:00 https://old.international-biopharma.com/biogen-loses-patent-dispute-with-mylan-putting-its-top-drugs-future-in-doubt/ 2020-06-22T08:47:36+00:00 https://old.international-biopharma.com/agios-seeking-a-new-strategy-touts-positive-data-and-marketing-deal/ 2020-06-15T09:45:20+00:00 https://old.international-biopharma.com/regeneron-brings-first-covid-19-antibody-cocktail-into-human-tests/ 2020-06-15T09:43:43+00:00 https://old.international-biopharma.com/moderna-to-start-in-july-what-could-be-first-late-stage-coronavirus-vaccine-trial/ 2020-06-15T09:40:08+00:00 https://old.international-biopharma.com/new-crispr-gene-therapy-results-strengthen-potential-for-treatment-of-blood-diseases/ 2020-06-15T09:36:38+00:00 https://old.international-biopharma.com/case-for-hydroxychloroquine-in-covid-19-fades-as-key-uk-study-finds-no-benefit/ 2020-06-08T09:13:16+00:00 https://old.international-biopharma.com/astrazeneca-puts-55m-into-accent-as-pharmas-continue-push-to-drug-rna/ 2020-06-08T09:09:31+00:00 https://old.international-biopharma.com/fresh-off-asco-myeloma-data-legend-bio-gets-424m-in-biotechs-biggest-ipo-of-2020/ 2020-06-08T09:05:56+00:00 https://old.international-biopharma.com/amid-a-pandemic-atlas-becomes-latest-venture-firm-to-raise-cash-for-drug-startups/ 2020-06-08T09:03:11+00:00 https://old.international-biopharma.com/sgs-joins-forces-with-leading-biotech-reithera-to-fast-track-its-single-dose-covid-19-vaccine/ 2020-06-05T08:29:07+00:00 https://old.international-biopharma.com/gilead-puts-375m-into-arcus-in-latest-push-to-broaden-cancer-business/ 2020-06-01T08:44:07+00:00 https://old.international-biopharma.com/facing-vial-shortage-pharmas-explore-workarounds-for-coronavirus-vaccines/ 2020-06-01T08:42:12+00:00 https://old.international-biopharma.com/contaminated-diabetes-drugs-raise-red-flag-for-fda-oversight/ 2020-06-01T08:37:49+00:00 https://old.international-biopharma.com/lilly-wins-first-ever-fda-approval-for-drug-that-can-spot-alzheimers-tau-tangles/ 2020-06-01T08:35:49+00:00 https://old.international-biopharma.com/more-questions-than-answers-as-modernas-coronavirus-vaccine-speeds-ahead/ 2020-05-26T10:07:14+00:00 https://old.international-biopharma.com/us-secures-supply-of-astrazeneca-oxford-coronavirus-vaccine-pledging-more-than-1b/ 2020-05-26T10:00:08+00:00 https://old.international-biopharma.com/coronavirus-study-in-china-shows-cansinos-vaccine-spurs-immune-responses/ 2020-05-26T09:30:01+00:00 https://old.international-biopharma.com/new-study-details-show-remdesivir-speeds-covid-19-recovery-but-doesnt-help-sickest-patients/ 2020-05-26T09:26:33+00:00 https://old.international-biopharma.com/thermo-fisher-to-invest-180m-in-new-gene-therapy-plant/ 2020-05-18T10:12:27+00:00 https://old.international-biopharma.com/myokardia-pops-as-heart-drug-passes-most-important-test/ 2020-05-18T10:06:57+00:00 https://old.international-biopharma.com/gilead-licenses-covid-19-drug-to-5-generics-companies/ 2020-05-18T10:04:15+00:00 https://old.international-biopharma.com/jj-myeloma-data-heat-up-cell-therapy-battle/ 2020-05-18T10:00:52+00:00 https://old.international-biopharma.com/novartis-wins-approval-for-niche-lung-cancer-drug/ 2020-05-11T09:09:56+00:00 https://old.international-biopharma.com/after-donation-to-the-u-s-gilead-outlines-plans-to-distribute-covid-19-drug-worldwide/ 2020-05-11T09:02:17+00:00 https://old.international-biopharma.com/moderna-plans-earlier-start-to-late-stage-test-of-coronavirus-vaccine/ 2020-05-11T09:00:08+00:00 https://old.international-biopharma.com/a-coronavirus-vaccine-may-arrive-next-year-herd-immunity-will-take-longer/ 2020-05-11T08:51:58+00:00 https://old.international-biopharma.com/regeneron-sanofi-immunotherapy-extends-survival-in-previously-untreated-lung-cancer/ 2020-05-04T09:24:25+00:00 https://old.international-biopharma.com/axsome-beating-the-odds-finds-success-treating-alzheimers-agitation/ 2020-05-04T09:20:57+00:00 https://old.international-biopharma.com/repurposed-arthritis-drug-disappoints-in-closely-watched-covid-19-trial/ 2020-05-04T09:17:35+00:00 https://old.international-biopharma.com/pharmas-boosted-by-drug-stockpiling-but-warn-of-covid-19-impact/ 2020-05-04T09:13:45+00:00 https://old.international-biopharma.com/malaria-drugs-potential-against-coronavirus-dims-as-data-mounts/ 2020-04-27T09:37:29+00:00 https://old.international-biopharma.com/why-120m-for-affinivax-may-reflect-a-new-view-of-vaccine-makers/ 2020-04-27T09:32:19+00:00 https://old.international-biopharma.com/coronavirus-puts-on-hold-launch-plans-for-neurocrines-parkinsons-drug/ 2020-04-27T09:28:57+00:00 https://old.international-biopharma.com/sanofi-ceo-cautions-arthritis-drug-a-long-shot-in-covid-19-says-study-results-imminent/ 2020-04-27T09:22:27+00:00 https://old.international-biopharma.com/astrazeneca-and-merck-drug-wins-approval-for-rare-cancer-after-failing-elsewhere/ 2020-04-20T08:31:24+00:00 https://old.international-biopharma.com/in-rare-move-sanofi-and-gsk-ally-on-coronavirus-vaccine-development/ 2020-04-20T08:28:35+00:00 https://old.international-biopharma.com/merck-samsung-join-newly-crowded-market-for-herceptin-biosimilars/ 2020-04-20T08:25:44+00:00 https://old.international-biopharma.com/as-ebola-drug-review-starts-regeneron-hopes-to-chart-similar-path-for-coronavirus-therapy/ 2020-04-20T08:24:04+00:00 https://old.international-biopharma.com/ultragenyxs-gene-therapy-technology-finds-another-interested-party/ 2020-04-06T09:43:46+00:00 https://old.international-biopharma.com/contamination-concerns-spur-fda-call-for-nationwide-withdrawal-of-heartburn-drug/ 2020-04-06T09:39:29+00:00 https://old.international-biopharma.com/under-pressure-fda-touts-speedy-coronavirus-drug-development/ 2020-04-06T09:37:23+00:00 https://old.international-biopharma.com/novartis-gives-up-on-planned-1b-generic-drug-sale-to-aurobindo/ 2020-04-06T09:34:14+00:00 https://old.international-biopharma.com/leukemia-drug-from-roche-abbvie-extends-survival-study-finds/ 2020-03-30T09:26:56+00:00 https://old.international-biopharma.com/china-halts-import-of-bristol-myers-cancer-drug-after-inspection-at-us-plant/ 2020-03-30T09:21:53+00:00 https://old.international-biopharma.com/astrazeneca-turns-again-to-uks-silence-in-renewed-rnai-push/ 2020-03-30T09:18:55+00:00 https://old.international-biopharma.com/sanofi-adds-mrna-to-coronavirus-vaccine-push/ 2020-03-30T09:14:30+00:00 https://old.international-biopharma.com/regeneron-expects-its-antibody-cocktail-for-coronavirus-to-enter-human-testing-in-early-summer/ 2020-03-23T10:45:48+00:00 https://old.international-biopharma.com/pharma-salesforces-brought-to-a-halt-as-coronavirus-shutters-economy/ 2020-03-23T10:35:07+00:00 https://old.international-biopharma.com/sage-redraws-its-plans-for-failed-antidepressant-drug/ 2020-03-23T10:33:25+00:00 https://old.international-biopharma.com/new-sickle-cell-drugs-priced-too-high-icer-says/ 2020-03-23T10:30:57+00:00 https://old.international-biopharma.com/acceleron-shelves-drug-after-disappointing-readout/ 2020-03-16T09:55:42+00:00 https://old.international-biopharma.com/coronavirus-spread-prompts-fda-to-postpone-nearly-all-overseas-inspections/ 2020-03-16T09:54:30+00:00 https://old.international-biopharma.com/gates-wellcome-hatch-125m-plan-to-speed-coronavirus-treatments/ 2020-03-16T09:52:54+00:00 https://old.international-biopharma.com/as-coronavirus-spreads-a-biotech-ipo-squeaks-through-others-may-wait-and-see/ 2020-03-16T09:49:42+00:00 https://old.international-biopharma.com/biogen-sangamo-look-to-tackle-alzheimers-parkinsons-through-gene-regulation-2/ 2020-03-09T09:39:07+00:00 https://old.international-biopharma.com/cell-therapy-developer-unum-restructures-cutting-staff-in-pivot/ 2020-03-09T09:35:35+00:00 https://old.international-biopharma.com/sanofi-wins-us-approval-for-myeloma-drug-key-to-its-cancer-ambitions/ 2020-03-09T09:34:02+00:00 https://old.international-biopharma.com/a-closer-look-at-the-ebola-drug-thats-become-the-top-hope-for-a-coronavirus-treatment/ 2020-03-09T09:31:22+00:00 https://old.international-biopharma.com/amgen-heart-drug-passes-interim-check-setting-up-year-end-readout/ 2020-03-02T09:46:37+00:00 https://old.international-biopharma.com/fda-pushes-back-decision-on-zogenix-epilepsy-drug/ 2020-03-02T09:44:56+00:00 https://old.international-biopharma.com/biogen-sangamo-look-to-tackle-alzheimers-parkinsons-through-gene-regulation/ 2020-03-02T09:33:37+00:00 https://old.international-biopharma.com/fda-reports-first-drug-shortage-due-to-coronavirus-impact/ 2020-03-02T09:31:27+00:00 https://old.international-biopharma.com/fda-responds-to-coronavirus-outbreak/ 2020-02-24T10:08:54+00:00 https://old.international-biopharma.com/fda-smooths-transition-of-biologic-approvals/ 2020-02-24T10:00:31+00:00 https://old.international-biopharma.com/fda-grants-breakthrough-therapy-designation-to-astellas-and-seattle-genetics-therapy-in-combination-with-merck-therapy/ 2020-02-24T09:55:25+00:00 https://old.international-biopharma.com/gsk-and-immatics-in-550-million-pact-to-develop-adoptive-cell-therapies/ 2020-02-24T09:50:47+00:00 https://old.international-biopharma.com/abbott-launches-new-four-strain-flu-vaccine-for-influenza/ 2020-02-24T09:48:07+00:00 https://old.international-biopharma.com/sanofi-ms-drug-results-set-stage-for-extensive-late-stage-testing/ 2020-02-13T16:18:36+00:00 https://old.international-biopharma.com/abbvies-plan-to-replace-humira-is-ahead-of-schedule/ 2020-02-13T16:17:34+00:00 https://old.international-biopharma.com/are-novartis-and-regeneron-seeing-the-same-thing/ 2020-02-13T16:16:30+00:00 https://old.international-biopharma.com/exelixis-prostate-cancer-data-could-help-stave-off-competitive-threats/ 2020-02-13T16:15:07+00:00 https://old.international-biopharma.com/merck-joins-peers-in-spinning-off-lower-growth-drugs/ 2020-02-10T09:35:54+00:00 https://old.international-biopharma.com/bristol-myers-launches-biotech-targeting-fibrosis-inflammation/ 2020-02-10T09:34:41+00:00 https://old.international-biopharma.com/regeneron-partners-with-us-government-to-develop-coronavirus-treatment/ 2020-02-10T09:32:45+00:00 https://old.international-biopharma.com/nestle-boosts-investment-as-aimmune-preps-launch-of-peanut-allergy-drug/ 2020-02-10T09:31:04+00:00 https://old.international-biopharma.com/cell-therapy-challenges-and-perspectives/ 2020-02-03T11:18:50+00:00 https://old.international-biopharma.com/modelling-cancer-for-immuno-oncology-applications-past-present-future/ 2020-02-03T11:15:33+00:00 https://old.international-biopharma.com/is-liver-biopsy-a-gold-or-an-old-standard-in-nafl-and-nash/ 2020-02-03T11:04:52+00:00 https://old.international-biopharma.com/split-butterfly-valve-technology-and-eradicating-the-risk-of-contamination-in-biologics-manufacturing/ 2020-02-03T11:01:14+00:00 https://old.international-biopharma.com/meeting-the-standards-required-for-effective-biorepository-management/ 2020-02-03T10:56:29+00:00 https://old.international-biopharma.com/is-the-absence-of-data-integrity-software-affecting-the-assurance-of-gel-clot-assays-in-bacterial-endotoxin-testing/ 2020-02-03T10:52:52+00:00 https://old.international-biopharma.com/best-practices-of-iot-implementation-for-smart-drug-research/ 2020-02-03T10:19:55+00:00 https://old.international-biopharma.com/managing-global-supply-chains/ 2020-02-03T10:16:27+00:00 https://old.international-biopharma.com/brexit-day-arrives-industry-continues-to-face-lack-of-clarity-as-transition-period-begins/ 2020-02-03T09:57:18+00:00